
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
In this clip, Rabia Atayee, PharmD, president of the Society of Palliative Care Pharmacists, discusses training opportunities available for pharmacists interested in palliative care.
In this clip, Rabia Atayee, PharmD, president of the Society of Palliative Care Pharmacists, discusses training opportunities available for pharmacists interested in palliative care.
For more information, visit http://www.palliativepharmacist.org.






